Remodeling of Cell-Cell Junctions in Arrhythmogenic Cardiomyopathy

REFERENCES

• Asimaki A, Saffitz JE (2012). Gap junctions and arrhythmogenic cardiomyopathy. Heart Rhythm. 9: 992–995.
   PubMed Web of Science ®Google Scholar
• Asimaki A, Tandri H, Duffy ER, Winterfield JR, Mackey-Bojack S, Picken MM, Cooper LT, Wilber DJ, Marcus FI, Basso C, Thiene G, Tsatsopoulou A, Protonotarios N, Stevenson WG, McKenna WJ, Gautam S, Remick DG, Calkins H, Saffitz JE (2011). Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 4: 743–752.
   PubMed Web of Science ®Google Scholar
• Asimaki A, Tandri H, Huang H, Halushka MK, Gautam S, Basso C, Thiene G, Tsatsopoulou A, Protonotarios N, McKenna WJ, Calkins H, Saffitz JE (2009). A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 360: 1075–1084.
   PubMed Web of Science ®Google Scholar
• Basso C, Czarnowska E, Della Barbera M, Bauce B, Beffagna G, Wlodarska EK, Pilichou K, Ramondo A, Lorenzon A, Wozniek O, Corrado D, Datiento L, Danieli GA, Valente M, Nava A, Thiene G, Rampazzo A (2006). Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy investigation on endomyocardial biopsies. Eur Heart J. 27: 1847–1854.
   PubMed Web of Science ®Google Scholar
• Bauce B, Basso C, Rampazzo A, Beffagna G, Daliento L, Frigo G, Malacrida S, Settimo L, Danieli G, Thiene G, Nava A (2005). Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J. 26: 1666–1675.
   PubMed Web of Science ®Google Scholar
• Beffagna G, Occhi G, Nava A, Vitiello L, Ditadi A, Basso C, Bauce B, Carraro G, Thiene G, Towbin JA, Danieli GA, Rampazzo A (2005). Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res. 65: 366–373.
   PubMed Web of Science ®Google Scholar
• Bengtsson L, Otoo H (2008). LUMA interacts with emerin and influences its distribution at the inner nuclear membrane. J Cell Sci. 121: 536–548.
   PubMed Web of Science ®Google Scholar
• Bierkamp C, Mclaughlin KJ, Schwarz H, Huber O, Kemler R (1996). Embryonic heart and skin defects in mice lacking plakoglobin. Dev Biol. 180: 780–785.
   PubMed Web of Science ®Google Scholar
• Borjesson M, Pelliccia A (2009). Incidence and aetiology of sudden cardiac death in young athletes: an international perspective. Br J Sports Med. 43: 644–648.
   PubMed Web of Science ®Google Scholar
• Carvajal-Huerta L (1998). Epidermolytic palmoplantar keratoderma with woolly hair and dilated cardiomyopathy. J Am Acad Dermatol. 39: 418–421
   PubMed Web of Science ®Google Scholar
• Cerrone M, Noorman M, Lin X, Chkourko H, Liang FX, van der Nagel R, Hund T, Birchmeier W, Mohler P, van Veen TA, van Rijen HV, Delmar M (2012). Sodium current deficit and arrhythmogenesis in a murine model of plakophilin-2 haploinsufficiency. Cardiovasc Res. 95: 460–468.
   PubMed Web of Science ®Google Scholar
• Christensen AH, Andersen CB, Tybjaerg-Hansen A, Haunso S, Svendsen JH (2011). Mutation analysis and evaluation of the cardiac localization of TMEM43 in arrhythmogenic right ventricular cardiomyopathy. Clin Genet. 80: 256–264.
   PubMed Web of Science ®Google Scholar
• Coonar AS, Protonotarios N, Tsatsopoulou A, Needham EW, Houlston RS, Cliff S, Otter MI, Murday VA, Mattu RK, McKenna WJ (1998). Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21. Circulation. 97: 2049–2058.
   PubMed Web of Science ®Google Scholar
• Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G (2006). Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. Jama-J Am Med Assoc. 296: 1593–1601.
   PubMed Web of Science ®Google Scholar
• Corrado D, Basso C, Thiene G (2000). Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment. Heart. 83: 588–595.
   PubMed Web of Science ®Google Scholar
• Delmar M (2012). Desmosome- ion channel interactions and their possible role in arrhythmogenic cardiomyopathy. Pediatr Cardiol. 33: 975–979.
   PubMed Web of Science ®Google Scholar
• Deo M, Sato PY, Musa H, Lin X, Pandit SV, Delmar M, Berenfeld O (2011). Relative contribution of changes in sodium current versus intercellular coupling on reentry initiation in 2-dimensional preparations of plakophilin- 2-deficient cardiac cells. Heart Rhythm. 8: 1740–1748.
   PubMed Web of Science ®Google Scholar
• Gallicano GI, Kouklis P, Bauer C, Yin M, Vasioukhin V, Degenstein L, Fuchs E (1998). Desmoplakin is required early in development for assembly of desmosomes and cytoskeletal linkage. J Cell Biol. 143: 2009–2022.
   PubMedGoogle Scholar
• Garcia-Gras E, Lombardi R, Giocondo MJ, Willerson JT, Schneider MD, Khoury DS, Marian AJ (2006). Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest. 116: 2012–2021.
   PubMed Web of Science ®Google Scholar
• Grossmann KS, Grund C, Huelsken J, Behrend M, Erdmann B, Franke WW, Birchmeier W (2004). Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation. J Cell Biol. 167: 149–160.
   PubMed Web of Science ®Google Scholar
• Haghighi K, Kolokathis F, Gramolini AO, Waggoner JR, Pater L, Lynch RA, Fan GC, Tsiapras D, Parekh RR, Dorn GW II, MacLennan DH, Kremastinos DT, Kranias EG (2006). A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc Natl Acad Sci U S A. 103: 1388–1393.
   PubMed Web of Science ®Google Scholar
• Haghighi K, Kolokathis F, Pater L, Lynch RA, Asahi M, Gramolini AO, Fan GC, Tsiapras D, Hahn HS, Adamopoulos S, Liggett SB, Dorn GW, MacLennan DH, Kremastinos DT, Kranias E (2003). Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest. 111: 869–876.
   PubMed Web of Science ®Google Scholar
• Hariharan V, Provost J, Shah S, Konofagou E, Huang H (2012). Elevated strain and structural disarray occur at the right ventricular apex. Cardiovas Eng Technol. 3: 52–61.
   Google Scholar
• Hatsell S, Medina L, Merola J, Haltiwanger R, Cowin P (2003). Plakoglobin is O-glycosylated close to the N-terminal destruction box. J Biol Chem. 278: 37745–37752.
   PubMed Web of Science ®Google Scholar
• Huang H, Asimaki A, Lo D, McKenna W, Saffitz J (2008). Disparate effects of different mutations in plakoglobin on cell mechanical behavior. Cell Motil Cytoskeleton. 65: 964–978.
   PubMed Web of Science ®Google Scholar
• Kaplan SR, Gard JJ, Carvajal-Huerta L, Ruiz-Cabezas JC, Thiene G, Saffitz JE. (2004a).Structural and molecular pathology of the heart in Carvajal syndrome. Cardiovasc Pathol. 13: 26–32.
   PubMed Web of Science ®Google Scholar
• Kaplan SR, Gard JJ, Protonotarios N, Tsatsopoulou A, Spiliopoulou C, Anastasakis A, Squarcioni CP, McKenna WJ, Thiene G, Basso C, Brousse N, Fontaine G, Saffitz JE. (2004b). Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm. 1: 3–11.
   PubMed Web of Science ®Google Scholar
• Kapplinger JD, Landstrom AP, Salisbury BA, Callis TE, Pollevick GD, Tester DJ, Cox MG, Bhuiyan Z, Bikker H, Wiesfeld AC, Hauer RN, van Tintelen JP, Jongbloed JD, Calkins H, Judge DP, Wilde AA, Ackerman MJ (2011). Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. J Am Coll Cardiol. 57: 2317–2327.
   PubMed Web of Science ®Google Scholar
• Kim C, Wong J, Wen J, Wang S, Wang C, Spiering S, Kan NG, Forcales S, Puri PL, Leone TC, Marine JE, Calkins H, Kelly DP, Judge DP, Chen HS (2013). Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature. 494: 105–110.
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Fabritz L, Zwiener M, Witt H, Schäfers M, Zellerhoff S, Paul M, Athai T, Hiller KH, Baba HA, Breithardt G, Ruiz P, Wichter T, Levkau B (2006). Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation. 114: 1799–1806.
   PubMed Web of Science ®Google Scholar
• Lombardi R, da Graca Cabreira-Hansen M, Bell A, Fromm RR, Willerson JT, Marian AJ (2011). Nuclear plakoglobin is essential for differentiation of cardiac progenitor cells to adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circ Res. 109: 1342–1353.
   PubMed Web of Science ®Google Scholar
• Lyon RC, Mezzano V, Wright AT, Pfeiffer E, Chuang J, Banares K, Castaneda A, Ouyang K, Cui L, Contu R, Gu Y, Evans SM, Omens JH, Peterson KL, McCulloch AD, Sheikh F (2013). Connexin defects underlie arrhythmogenic right ventricular cardiomyopathy in a novel mouse model. Hum Mol Genet. [Epub ahead of print]
   Google Scholar
• MacLennan DH, Kranias EG (2003). Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol. 4: 566–577.
   PubMed Web of Science ®Google Scholar
• Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H, Corrado D, Cox MG, Daubert JP, Fontaine G, Gear K, Hauer R, Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DM, Steinberg JS, Tandri H, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W (2010). Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Circulation. 121: 1533–1541.
   PubMed Web of Science ®Google Scholar
• Marks AR, Priori S, Memmi M, Kontula K, Laitinen PJ (2002). Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia. J Cell Physiol. 190: 1–6.
   PubMed Web of Science ®Google Scholar
• McKenna WJ, Thiene G, Nava A, Fontaliron F, Blomstrom-Lundquist G, Fontaine G, Camerini F; on behalf of the Task Force of the working group myocardial and pericardial disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology (1994). Diagnosis of arrhythmogenic right ventricular dysplasia cardiomyopathy. Br Heart J. 71: 215–218.
   PubMedGoogle Scholar
• McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, Coonar A, Norman M, Baboonian C, Jeffery S, McKenna WJ (2000). Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 355: 2119–2124.
   PubMed Web of Science ®Google Scholar
• Merner ND, Hodgkinson KA, Haywood AF, Connors S, French VM, Drenckhahn JD, Kupprion C, Ramadanova K, Thierfelder L, McKenna W, Gallagher B, Morris-Larkin L, Bassett AS, Parfrey PS, Young TL (2008). Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet. 82: 809–821.
   PubMed Web of Science ®Google Scholar
• Nava A, Scognamiglio R, Thiene G, Canciani B, Daliento L, Buja G, Stritoni P, Fasoli G, Dalla Volta S (1987). A polymorphic form of familial arrhythmogenic right ventricular dysplasia. Am J Cardiol. 59: 1405–1409.
   PubMed Web of Science ®Google Scholar
• Noorman M, Hakim S, Kessler E, Groeneweg JA, Cox MG, Asimaki A, van Rijen HV, van Stuijvenberg L, Chkourko H, van der Heyden MA, Vos MA, de Jonge N, van der Smagt JJ, Dooijes D, Vink A, de Weger RA, Varro A, de Bakker JM, Saffitz JE, Hund TJ, Mohler PJ, Delmar M, Hauer RN, van Veen TA (2013). Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy. Heart Rhythm. 10: 412–419.
   PubMed Web of Science ®Google Scholar
• Norman M, Simpson M, Mogensen J, Shaw A, Hughes S, Syrris P, Sen-Chowdhry S, Rowland E, Crosby A, McKenna WJ (2005). Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation. 112: 636–642.
   PubMed Web of Science ®Google Scholar
• Otten E, Asimaki A, Maass A, van Langen IM, van der Wal A, de Jonge N, van den Berg MP, Saffitz JE, Wilde AA, Jongbloed JD, van Tintelen JP (2010). Desmin mutations as a cause of right ventricular heart failure affect the intercalated disks. Heart Rhythm. 7: 1058–1064.
   PubMed Web of Science ®Google Scholar
• Pilichou K, Remme CA, Basso C, Campian ME, Rizzo S, Barnett P, Scicluna BP, Bauce B, van den Hoff MJ, de Bakker JM, Tan HL, Valente M, Nava A, Wilde AA, Moorman AF, Thiene G, Bezzina CR (2009). Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy. J Exp Med. 206: 1787–1802.
   PubMed Web of Science ®Google Scholar
• Polychronopoulou S, Tsatsopoulou A, Papadhimitriou SI, Panagiotou JP, Anastasakis A, Paterakis G, Anagnostou D, Protonotarious N, Haidas SA (2002). Myelodysplasia and Naxos disease: a novel pathogenetic association?Leukemia. 16: 2335–2337.
   PubMed Web of Science ®Google Scholar
• Posch MG, Perrot A, Geier C, Boldt LH, Schmidt G, Lehmkuhl HB, Hetzer R, Dietz R, Gutberlet M, Haverkamp W, Ozcelik C (2009). Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes. Heart Rhythm. 6: 480–486.
   PubMed Web of Science ®Google Scholar
• Purkis PE, Whittock N, Leigh IM, Stevens HP, Kelsell DP (2000). Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum Mol Genet. 9: 2761–2766.
   PubMed Web of Science ®Google Scholar
• Rampazzo A, Nava A, Danieli GA, Buja G, Daliento L, Fasoli G, Scognamiglio R, Corrado D, Thiene G (1994). The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. Hum Mol Genet. 3: 959–962.
   PubMed Web of Science ®Google Scholar
• Rampazzo A, Nava A, Malacrida S, Beffagna G, Bauce B, Rossi V, Zimbello R, Simionati B, Basso C, Thiene G, Towbin JA, Danieli GA (2002). Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet. 71: 1200–1206.
   PubMed Web of Science ®Google Scholar
• Rizzo S, Lodder EM, Verkerk AO, Wolswinkel R, Beekman L, Pilichou K, Basso C, Remme CA, Thiene G, Bezzina CR (2012). Intercalated disc abnormalities, reduced Na(+) current density, and conduction slowing in desmoglein-2 mutant mice prior to cardiomyopathic changes. Cardiovasc Res. 95: 409–418.
   PubMed Web of Science ®Google Scholar
• Romero J, Mejia-Lopez E, Manrique C, Lucariello R (2013). Arrhythmogenic right ventricular cardiomyopathy (ARVC/D): a systematic literature review. Clin Med Ins Cardiol l7: 97–114.
   Google Scholar
• Rubenstein A, Merriam J, Klymkowsky MW (1997). Localizing the adhesive and signaling functions of plakoglobin. Dev Genet. 20: 91–102.
   PubMedGoogle Scholar
• Sadot E, Simcha I, Iwai K, Ciechanover A, Geiger B, Ben-Ze'ev A (2000). Differential interaction of plakoglobin and β-catenin with the ubiquitin-proteasome system. Oncogene. 19: 1992–2000.
   PubMed Web of Science ®Google Scholar
• Saffitz JE (2003). Dependence of electrical coupling on mechanical coupling in cardiac myocytes. In: Thiene G, Dessina AC (eds). Advances in Cardiovascular Medicine. Padua, Italy: Universitá degli Studi di Padova . pp. 15–28.
   Google Scholar
• Saffitz JE, Asimaki A, Huang H (2010). Arrhythmogenic right ventricular cardiomyopathy: new insights into mechanisms of disease. Cardiovasc Pathol. 19: 166–170.
   PubMed Web of Science ®Google Scholar
• Saffitz JE, Asimaki A, Huang H (2009). Arrhythmogenic right ventricular cardiomyopathy: new insights into disease mechanisms and diagnosis. J Investig Med. 57: 861–864.
   PubMed Web of Science ®Google Scholar
• Saffitz JE (2009). Arrhythmogenic cardiomyopathy and abnormalities of cell-to-cell coupling. Heart Rhythm. 8: S62–S65.
   Google Scholar
• Saffitz JE (2011). The pathobiology of arrhythmogenic cardiomyopathy. Annu Rev Pathol. 6: 299–321.
   PubMed Web of Science ®Google Scholar
• Sato PY, Coombs W, Lin XM, Nekrasova O, Green KJ, Isom LL, Taffet SM, Delmar M (2011). Interactions between ankyrin-g, plakophilin-2, and connexin43 at the cardiac intercalated disc. Circ Res. 109: 193–U160.
   PubMed Web of Science ®Google Scholar
• Sato PY, Musa H, Coombs W, Guerrero-Serna G, Patiño GA, Taffet SM, Isom LL, Delmar M (2009). Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes. Circ Res. 105: 523–526.
   PubMed Web of Science ®Google Scholar
• Schmitt JP, Kamisago M, Asahi M, Li GH, Ahmad F, Mende U, Kranias EG, MacLennan DH, Seidman JG, Seidman CE (2003). Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science. 299: 1410–1413.
   PubMed Web of Science ®Google Scholar
• Sen-Chowdhry S, Morgan RD, Chambers JC, McKenna WJ (2010). Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment. Annu Rev Med. 61: 233–253.
   PubMed Web of Science ®Google Scholar
• Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna WJ (2007). Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation. 115: 1710–1720.
   PubMed Web of Science ®Google Scholar
• Shen WK, Edwards WD, Hammill SC, Gersh BJ (1994). Right ventricular dysplasia: a need for precise pathological definition for interpretation of sudden death. Am Coll Cardiol. 23: 34A.
   Google Scholar
• Tabib A, Loire R, Chalabreysse L, Meyronnet D, Miras A, Malicier D, Thivolet F, Chevalier P, Bouvagnet P (2003). Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/ or dysplasia. Circulation. 108: 3000–3005.
   PubMed Web of Science ®Google Scholar
• Thiene G, Corrado D, Basso C (2007). Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Orphanet J Rare Dis. 2: 45–61.
   PubMed Web of Science ®Google Scholar
• Thiene G, Nava A, Corrado D, Rossi L, Pennelli N (1988). Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 318: 129–133.
   PubMed Web of Science ®Google Scholar
• Tiso N, Stephan DA, Nava A, Bagattin A, Devaney JM, Stanchi F, Larderet G, Brahmbhatt B, Brown K, Bauce B, Muriago M, Basso C, Thiene G, Danieli GA, Rampazzo A (2001). Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet. 10: 189–194.
   PubMed Web of Science ®Google Scholar
• van de Schans VA, Smits JF, Blankesteijn WM (2008). The Wnt/frizzled pathway in cardiovascular development and disease: friend or foe?Eur J Pharmacol. 585: 338–345.
   PubMed Web of Science ®Google Scholar
• van der Zwaag PA, van Rijsingen IA, Asimaki A, Jongbloed JD, van Veldhuisen DJ, Wiesfeld AC, Cox MG, van Lochem LT, de Boer RA, Hofstra RM, Christiaans I, van Spaendonck-Zwarts KY, Lekanne dit Deprez RH, Judge DP, Calkins H, Suurmeijer AJ, Hauer RN, Saffitz JE, Wilde AA, van den Berg MP, van Tintelen JP (2012). Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur J Heart Fail. 14: 1199–1207.
   PubMed Web of Science ®Google Scholar
• van Tintelen JP, Entius MM, Bhuiyan ZA, Jongbloed R, Wiesfeld AC, Wilde AA, van der Smagt J, Boven LG, Mannens MM, van Langen IM, Hofstra RM, Otterspoor LC, Doevendans PA, Rodriguez LM, van Gelder IC, Hauer RN (2006). Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation. 113: 1650–1658.
   PubMed Web of Science ®Google Scholar
• Xu T, Yang Z, Vatta M, Rampazzo A, Beffagna G, Pilichou K, Scherer SE, Saffitz J, Kravitz J, Zareba W, Danieli GA, Lorenzon A, Nava A, Bauce B, Thiene G, Basso C, Calkins H, Gear K, Marcus F, Towbin JA; Multidisciplinary Study of Right Ventricular Dysplasia Investigators (2010). Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 55: 587–597.
   PubMed Web of Science ®Google Scholar
• Yang Z, Bowles NE, Scherer SE, Taylor MD, Kearney DL, Ge S, Nadvoretskiy VV, DeFreitas G, Carabello B, Brandon LI, Godsel LM, Green KJ, Saffitz JE, Li H, Danieli GA, Calkins H, Marcus F, Towbin JA (2006). Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Res. 99: 646–655.
   PubMed Web of Science ®Google Scholar